Clinical Trial

Impact of CADx on Endoscopists' Histologic Characterization of Diminutive Colorectal Polyps

Completed
View on ClinicalTrials.gov →
Summary
This study evaluates the impact of CADx assistance on endoscopists' histologic characterization of diminutive colorectal polyps (≤5 mm) during colonoscopy. The primary objective is to determine whether CADx assistance increases the proportion of endoscopists who meet PIVI-related performance thresholds, thereby supporting implementation of the "resect and discard" and "diagnose and leave" strategies in routine clinical practice.
Protocol Amendment History 6 changes
critical Trial completed 2026-07-08
notable Primary completion moved earlier: 2026-04-30 -> 2026-03-31 2026-07-08
minor Completion moved earlier: 2026-04-30 -> 2026-03-31 2026-07-08
critical Trial status changed: Not Yet Recruiting → Active, Not Recruiting 2026-04-16
notable Primary completion pushed: 2026-03-31 -> 2026-04-30 2026-04-16
minor Completion pushed: 2026-03-31 -> 2026-04-30 2026-04-16
Trial Details
NCT Number NCT07389759
Lead Sponsor Shanghai Jiao Tong University School of Medicine
Conditions Colorectal Polyps
Enrollment 399 participants
Start Date 2026-01-03
Primary Completion 2026-03-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-07